Thank you to our sponsors!
Centivo
Elite
Centivo is a new type of digital health plan anchored around leading providers of value-based care. Centivo saves self-funded employers 15 percent or more compared to traditional insurance carriers and is easy to use for employers and employees. Our mission is to bring lower cost, higher quality healthcare to the millions of working Americans who struggle to pay their healthcare bills. With Centivo, employers can offer their employees affordable and predictable costs, a high-tech member experience, exceptional service, and a range of benefit options including both proprietary primary care-centered ACO models as well as traditional networks. For more information, visit centivo.com or follow us @Centivo on LinkedIn or @CentivoHealth on Twitter.
National Pharmaceutical Council
Elite
National Pharmaceutical CouncilThe National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.
Novo Nordisk
Elite
Novo Nordisk, a global health care company, has been committed to discovering and developing innovative medicines to help people with serious chronic conditions lead longer, healthier lives with fewer limitations. We’re working toward a future where fewer people get chronic diseases, everyone is diagnosed, and all patients receive adequate treatment
Biosimilars Forum
Platinum
The Biosimilars Forum was incorporated in Washington, DC, as a nonprofit organization to advance biosimilars in the United States with the intent of expanding access and availability of biological medicines, and improving health care. The Biosimilars Forum will provide evidence-based information to inform and support public policies that encourage awareness, access, and adoption of biosimilars.
The introduction of biosimilars in the United States may help expand access to high-quality treatment options for clinicians and patients as well as potentially reduce costs to families, caregivers, payers, and the entire health care system. Using state-of-the-art technology, biosimilars are manufactured using the same with the same high-quality systems and processes as existing biological medicines.
The FDA approval of the first biosimilar in the United States and the ongoing development and production of other biosimilars serve as important milestones. The founding members and key stakeholders recognize there is a need for a sustained and unbiased biosimilars education and advocacy program in the U.S.
To this end, the development of an independent non-profit forum to raise awareness of biosimilars and serve as a credible resource for information is timely. The Biosimilars Forum will provide an opportunity for companies developing biosimilars for the U.S. to work together and with other key stakeholders on topics instrumental to biosimilars and patient care.
Learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org, or go to @USBiosimilars to follow related conversations and join the dialogue.
The introduction of biosimilars in the United States may help expand access to high-quality treatment options for clinicians and patients as well as potentially reduce costs to families, caregivers, payers, and the entire health care system. Using state-of-the-art technology, biosimilars are manufactured using the same with the same high-quality systems and processes as existing biological medicines.
The FDA approval of the first biosimilar in the United States and the ongoing development and production of other biosimilars serve as important milestones. The founding members and key stakeholders recognize there is a need for a sustained and unbiased biosimilars education and advocacy program in the U.S.
To this end, the development of an independent non-profit forum to raise awareness of biosimilars and serve as a credible resource for information is timely. The Biosimilars Forum will provide an opportunity for companies developing biosimilars for the U.S. to work together and with other key stakeholders on topics instrumental to biosimilars and patient care.
Learn more about biosimilars, the Forum, and how to get involved, visit BiosimilarsForum.org, or go to @USBiosimilars to follow related conversations and join the dialogue.
Certilytics
Platinum
Certilytics is the leading data and predictive analytics partner transforming some of our country’s largest employers. Certilytics’ solutions enable employers to thrive in a value-focused healthcare ecosystem by identifying opportunities, inspiring action, improving health outcomes, and exceeding financial targets.
Carrum Health
Gold
Carrum Health is on a mission to "bring common sense to healthcare" through a value-based healthcare model that benefits families, employers, and providers. Carrum's award-winning surgery benefits platform connects self-insured employers with top providers under standardized bundled payment arrangements to better manage healthcare costs. By aligning provider incentives with quality performance, Carrum drives improvements in patient experience and health outcomes. Customers include large Fortune 500 companies and public sector organizations.
Nox Health
Gold
Nox Health® is a telehealth company focused on sleep. SleepCharge® is our solution. SleepCharge evaluates, diagnoses and treats sleep issues to help people get the rest they need. We combine technology and personalized care with behavioral and medical therapies to lower health care costs, improve outcomes and support members on their journey to better health.
Pear Therapeutics
Gold
Pear Therapeutics is the pioneer in Prescription Digital Therapeutics (PDTs), a new therapeutic class that uses software to treat disease.Our groundbreaking PDTs, reSET®, reSET-O® and Somryst® deliver new pathways to treat substance use disorder (SUD), opioid use disorder (OUD), and Chronic Insomnia, respectively.
Total Brain
Gold
Total Brain is a digital neurotech company with 20 years of scientific research. Total Brain enables self-monitoring of the 12 brain capacities that define mental health and the risk of common mental health conditions. With just 20 minutes of self-monitoring per month and 15 minutes of self-care per day, individuals can improve their self-awareness and brain performance. By confidentially monitoring and supporting the mental health and wellness of their organization, companies can achieve better health outcomes, lower pharmaceutical claims, and improve employee performance and productivity. For Providers, Total Brain’s clinically-validated assessment enables personalized treatment plans and tracking of evidence-based outcomes across the continuum of care. Digital self-care tools enable clinicians to support patients between therapy sessions with exercises that help develop cognitive and emotional skills that support recovery, including cognitive behavior therapy, breath, meditation, positivity, cognitive boosting, and, in the case of addiction, self-control exercises to help overcome cravings.
US-Rx Care
Gold
US-Rx Care is a Pharmacy Risk Management company that provides fiduciary compliant pharmacy benefit services that includes; Pharmacy Benefit Management, Specialty Pharmacy Management, Cost Optimization and Medical (J-Code) Specialty Management services. We serve over 5 million lives and have saved our clients over $1 Billion without member disruption.
ViiV Healthcare
Gold
ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Shionogi joined in October 2012. The company’s aims are to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support communities affected by HIV.
AccessHope
AccessHope believes in putting the ever-growing body of cancer knowledge to work for the greater good. The company delivers a revolutionary cancer benefit that connects employees with cancer to the renowned expertise of National Cancer Institute–Designated Comprehensive Cancer Centers. AccessHope is sharing the latest discoveries in cancer care while working with local oncologists to help develop precise plans for treatment. The company brings the vast expertise of major medical centers to people near and far. They never have to switch doctors. They never have to leave home. It’s simply a better approach to cancer care. And getting better every day. AccessHope serves more than 2 million members who have cancer support benefits through 49 employers, including 22 Fortune 1000 companies. For more information about AccessHope, visit myaccesshope.org.
National Cancer Treatment Alliance
Community Oncology Alliance (COA) has created the National Cancer Treatment Alliance (NCTA), a coalition of leading, independent community oncology practices across the country. The purpose of NCTA is to contract directly with employers for cancer drugs and services so that their employees have access to the highest quality, most affordable, and locally accessible cancer care. In developing a presence and relationship with employers and the business groups/coalitions representing them, NCTA will offer the expertise of its oncology network in providing information, resources, and educational materials for both employers and employees. NCTA will cover current, fundamental topics in oncology, both relating to its treatment and public policy, such as: • Optimizing cancer screening and prevention • Finding an oncologist: what to look for and what questions to ask • Understanding biosimilars and maximizing their use • How to navigate molecular diagnostic testing • Understanding immunotherapy and “precision medicine” • Enhancing the cancer survivorship journey • Navigating the opaque PBM rebate trap and Understanding how the 340B drug discount program benefits hospitals, not employers and their employees
Vida Health
Vida’s award-winning, evidence-based virtual polychronic care platform brings together the power of human connection, psychology, and expertise to drive the long-term behaviors that lead not only to better management of chronic conditions, but prevention and even reversal as well. The program is a mobile-first experience uniquely personalized to each user through a combination of provider expertise and machine learning algorithms that use data from 100+ app and device integrations, as well as medical claims data, biometric data, and more to personalize the program and content.
Vida is polychronic by design and so naturally offers programs to treat a full spectrum of chronic conditions and the behavioral conditions that accompany them. Vida’s program offerings are grounded in the belief that every chronic condition is also a behavioral condition, and that good health follows good habits. Vida’s users accomplish lasting results through treating the body and the mind.
Vida is polychronic by design and so naturally offers programs to treat a full spectrum of chronic conditions and the behavioral conditions that accompany them. Vida’s program offerings are grounded in the belief that every chronic condition is also a behavioral condition, and that good health follows good habits. Vida’s users accomplish lasting results through treating the body and the mind.
AMPS
Advanced Medical Pricing Solutions (AMPS) provides market leading healthcare cost containment solutions serving self-funded employers, brokers, TPAs, health systems, health plans, and reinsurers. AMPS mission is to help clients attain their goals of reducing medical and pharmacy costs while keeping members satisfied with quality healthcare benefits. AMPS leverages its 15+ years of experience and data in auditing and pricing medical claims to deliver "fair for all" pricing. AMPS offers detailed analytics and transparency to provide clients with insights based on plan performance. Learn more at www.amps.com.
HealthSmartRx Solutions
HealthSmartRx Solutions (HSRx) is an innovative manager of pharmacy manufacturer assistance programs that reduce the high cost of specialty drugs for both the plan sponsor and member alike.
For example, HSRx’s best-in-class Copay Maximizer program offers self-funded plans a turnkey, bolt-on solution to lower member and plan costs of high-cost specialty drugs across both the medical and pharmacy benefit. Copay Maximizer captures savings associated with coupon and copay cards for over 400 pharmacy benefit drugs and more than 200 infused drugs under the medical benefit.
To learn more about our innovative Rx cost containment strategies, visit us at HealthSmartRxSolutions.com.
For example, HSRx’s best-in-class Copay Maximizer program offers self-funded plans a turnkey, bolt-on solution to lower member and plan costs of high-cost specialty drugs across both the medical and pharmacy benefit. Copay Maximizer captures savings associated with coupon and copay cards for over 400 pharmacy benefit drugs and more than 200 infused drugs under the medical benefit.
To learn more about our innovative Rx cost containment strategies, visit us at HealthSmartRxSolutions.com.
Hydrogen Health
Hydrogen’s advanced virtual primary care is designed to help your team thrive, delivering better outcomes and lower costs for everyone. As leaders and experts in healthcare implementation, member engagement, and integrated, value-based care, Hydrogen helps enterprises and health plans bring K Health’s advanced virtual primary care solution to their populations. More than a provider or an administrator, Hydrogen is your partner in building more equitable healthcare and a better future for all.
SurgiQuality
SurgiQuality impels surgeons, surgery centers and hospitals to compete for surgical patients based on cost and surgeon’s outcomes measures, such as number of cases performed, success and complication rates. The platform is a powerful solution for black employees to level the playing field, when seeking surgical care.
Using a personalized concierge service and a HIPAA-compliant medical record distribution platform, surgeons review patient records, validate necessity of surgery, offer alternatives to surgery, and enter past outcomes. Patients are empowered with tools to compare surgeons using procedure-specific outcomes measures and then can make well informed decisions.
Using a personalized concierge service and a HIPAA-compliant medical record distribution platform, surgeons review patient records, validate necessity of surgery, offer alternatives to surgery, and enter past outcomes. Patients are empowered with tools to compare surgeons using procedure-specific outcomes measures and then can make well informed decisions.
TabulaRasa
Tabula Rasa HealthCare‘s (TRHC) division, MedWise HealthCare, provides medication safety solutions that empower healthcare organizations to optimize medication regimens, reducing adverse drug events. TRHC’s propriety technology, MedWise® Science, delivers simultaneous, multi-drug analyses that identify medication-related risks to prevent hospitalizations and emergency room visits. Peer-reviewed research demonstrates how pharmacist-led interventions provide actionable insights to reduce patient risk, resulting in improved health outcomes and reduced medical costs. Our extensive clinical network facilitates our programs that help drive value-based care, which improve medication efficacy and adherence, leading to better outcomes for patients nationwide.